STOCKWATCH
·
Major Chemicals
Quarterly ResultMay 14, 2026, 07:31 AM

Braskem 1Q26 Recurring EBITDA Jumps 76% to $192M

AI Summary

Braskem reported a 76% increase in consolidated Recurring EBITDA to US$192 million in 1Q26 compared to 4Q25, driven by strong performance in Brazil/South America and the United States & Europe segments. The Brazil/South America segment's EBITDA rose 69% to US$241 million, while the US & Europe segment turned positive at US$21 million. The company also noted a positive impact of US$32 million on COGS from the REIQ incentive and recorded a net income of US$275 million. However, the Mexico segment posted a negative EBITDA of US$15 million, and the company experienced operating cash consumption of R$3.2 billion.

Key Highlights

  • Consolidated Recurring EBITDA increased 76% to US$192 million in 1Q26.
  • Brazil/South America segment Recurring EBITDA rose 69% to US$241 million.
  • United States & Europe segment Recurring EBITDA turned positive at US$21 million.
  • Mexico segment Recurring EBITDA was negative US$15 million.
  • Net income attributable to shareholders was US$275 million (R$1.4 billion).
  • Positive impact on COGS of US$32 million from the REIQ incentive.
  • Operating cash consumption was R$3.2 billion in 1Q26.
  • Investments (ex-Braskem Idesa and REIQ Investimentos) totaled US$76 million.
BAK
Major Chemicals
BRASKEM SA

Price Impact